Legence Corp. Financials

Legence Corp. (LGN) reported $2.6B in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

No, Legence Corp. (LGN) reported a net income of -$59.8M in fiscal year 2025, with a net profit margin of -2.3%.

Legence Corp. (LGN) reported diluted earnings per share of $-0.57 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Legence Corp. (LGN) had EBITDA of $161.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Legence Corp. (LGN) had $230.2M in cash and equivalents against $84.7M in long-term debt.

Legence Corp. (LGN) had a gross margin of 21.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Legence Corp. (LGN) had an operating margin of 2.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Legence Corp. (LGN) had a net profit margin of -2.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Legence Corp. (LGN) has a return on equity of -15.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Legence Corp. (LGN) generated $218.9M in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Legence Corp. (LGN) generated $256.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Legence Corp. (LGN) had $2.7B in total assets as of fiscal year 2025, including both current and long-term assets.

Legence Corp. (LGN) invested $37.9M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Legence Corp. (LGN) had 67M shares outstanding as of fiscal year 2025.

Legence Corp. (LGN) had a current ratio of 1.57 as of fiscal year 2025, which is generally considered healthy.

Legence Corp. (LGN) had a debt-to-equity ratio of 0.22 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Legence Corp. (LGN) had a return on assets of -2.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Legence Corp. (LGN) has an Altman Z-Score of 2.28, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Legence Corp. (LGN) has an earnings quality ratio of -4.30x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Legence Corp. (LGN) has an interest coverage ratio of 4.6x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Legence Corp. (LGN) scores 40 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.